These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28971320)

  • 1. Expression of Genes for Methylxanthine Pathway-Associated Enzymes Accompanied by Sex Steroid Receptor Status Impacts Breast Carcinoma Progression.
    Wittliff JL; Sereff SB; Daniels MW
    Horm Cancer; 2017 Dec; 8(5-6):298-313. PubMed ID: 28971320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes linked to expression of gene subsets for protein hormones and their cognate receptors from LCM-procured breast carcinoma cells.
    Daniels MW; Brock GN; Wittliff JL
    Breast Cancer Res Treat; 2017 Jan; 161(2):245-258. PubMed ID: 27858316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas.
    Sereff SB; Daniels MW; Wittliff JL
    J Clin Lab Anal; 2019 Nov; 33(9):e22982. PubMed ID: 31359505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
    Liu D; Zhou K
    Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatase 4A2 expression predicts overall and disease-free survival of human breast cancer and is associated with estrogen and progestin receptor status.
    Andres SA; Wittliff JL; Cheng A
    Horm Cancer; 2013 Aug; 4(4):208-21. PubMed ID: 23568563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Uzelac B; Krivokuca A; Susnjar S; Milovanovic Z; Supic G
    Genet Test Mol Biomarkers; 2021 Mar; 25(3):227-235. PubMed ID: 33734898
    [No Abstract]   [Full Text] [Related]  

  • 8. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
    El-Gendi SM; Mostafa MF
    Pathol Oncol Res; 2016 Jul; 22(3):461-70. PubMed ID: 26597806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen.
    Kerr DA; Wittliff JL
    Horm Cancer; 2011 Oct; 2(5):261-71. PubMed ID: 21826535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease.
    Hilton HN; Doan TB; Graham JD; Oakes SR; Silvestri A; Santucci N; Kantimm S; Huschtscha LI; Ormandy CJ; Funder JW; Simpson ER; Kuczek ES; Leedman PJ; Tilley WD; Fuller PJ; Muscat GE; Clarke CL
    Oncotarget; 2014 Sep; 5(18):8651-64. PubMed ID: 25261374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
    Yau C; Benz CC
    Breast Cancer Res; 2008; 10(4):R61. PubMed ID: 18631401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differences and clinical significance of receptor expression between primary and locally recurrent breast tumor tissues].
    Ma XM; Han YW; Zhang J; Cui WJ; Wang X
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):372-6. PubMed ID: 24054015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
    Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
    J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrogating differences in expression of targeted gene sets to predict breast cancer outcome.
    Andres SA; Brock GN; Wittliff JL
    BMC Cancer; 2013 Jul; 13():326. PubMed ID: 23819905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
    Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
    Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
    Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
    Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Tiirikainen M; Yu H
    FEBS Open Bio; 2019 Jul; 9(7):1270-1280. PubMed ID: 31102318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.